Positions
- Professor
-
Medicine
Cardiovascular Research
Baylor College of Medicine
- Faculty Member
-
Development, Disease Models and Therapeutics (DDMT) Graduate Program
Baylor College of Medicine
- Faculty Member
-
Immunology & Microbiology Graduate Program
Baylor College of Medicine
Education
- Postdoctoral Fellowship at Baylor College Of Medicine
- 01/2012 - Houston, TX United States
- PhD from China Pharmaceutical University
- 07/2008 - Nanjing, China, People's Rep
Professional Interests
- To investigate novel molecular mechanisms underlying cardiac arrhythmias and cardiomyopathy.
Professional Statement
Cardiac arrhythmias can dramatically disrupt heart function and even be life-threatening. These irregular heartbeats may stem from faulty ion transporters or tissue remodeling. Our research is driving innovation in three key areas:1. Inflammatory Signaling in Atrial Fibrillation (AF) Pathogenesis: AF, the most common arrhythmia among adults, is becoming increasingly prevalent. We're diving deep into the connections between risk factors and AF pathophysiology, with a spotlight on inflammasome and FKBP5 signaling pathways to uncover groundbreaking insights.
2. Cardiac Conduction Disorder (CCD): CCD is widespread among those with heart failure, cardiomyopathy, or genetic conditions. Severe cases often require pacemaker implantation. Our mission is to decode the molecular underpinnings of CCD and pioneer novel therapies to transform patient care.
3. Rare Cardiac Arrhythmia - TANGO2 Deficiency Disorder (TDD): The TANGO2 gene is vital for cellular functions, especially in intracellular transport and Golgi organization. Mutations in TANGO2 can trigger TDD, a rare condition marked by metabolic crises. These episodes, spurred by infections, fasting, or stress, can cause severe cardiac arrhythmias, muscle breakdown (rhabdomyolysis), and brain disease (encephalopathy). We're leveraging genetic mouse models to unravel the molecular mechanisms of TDD and test potential therapies in preclinical trials.
The Li Lab is supported by research grants from the National Institutes of Health and the American Heart Association, fueling our quest to combat cardiac arrhythmias with cutting-edge science and innovative solutions.
Websites
Selected Publications
- Yao Y, ... Li N. "Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.." Circulation. 2018;
- Scott Jr. L,.... Li N. "NLRP3 Inflammasome Is a Key Driver of Obesity-Induced Atrial Arrhythmias." Cardiovasc Res. 2021; Pubmed PMID: 33523143
- Wang X, ... Li N. "Downregulation of FKBP5 Promotes Atrial Arrhythmogenesis." Circ Res. 2023; Pubmed PMID: 37154033
- Song J, ... Li N. "Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation." J Clin Invest. 2023; Pubmed PMID: 37581942
- Yuan Y, .... Li N. "Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis." European Heart Journal. 2025 Feb; Pubmed PMID: 39927987
- Li L, ... Li N. "Fibroblast-restricted inflammasome activation promotes atrial fibrillation and heart failure with diastolic dysfunction.." JACC Basic Transl Sci. 2025 Apr; Pubmed PMID: 40243956
Funding
- The Role of Gasdermin-D/Interleukin-1 Nexus in Atrial Arrhythmogenesis Grant funding from NIH/NHLBI
- Cardiac fibroblast inflammasome and atrial myopathy Grant funding from NIH/NHLBI
- Arrhythmogenesis associated with the TANGO2-deficiency Grant funding from American Heart Association
- FKBP5 AND CARDIAC ARRHYTHMOGENESIS Grant funding from NIH/NHLBI
Log In to edit your profile